Briefing
ctDNA as an Objective Marker for Postoperative Residual Disease in Primary Advanced High-Grade Serous Ovarian Cancer
ctDNA was evaluated as an objective marker of postoperative residual disease in primary advanced high-grade serous ovarian cancer.
- Design: Evidence level 3
- Assay: Not named in the abstract